Results 111 to 120 of about 16,702 (172)

Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gaps. [PDF]

Lancet HIV, 2022
Naidoo A, Naidoo K, Padayatchi N, Dooley KE.   +3 more
europepmc   +1 more source

Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. [PDF]

AIDS
Russo SC, Ockene MW, Arpante AK, Johnson JE, Lee H, Toribio M, Stanley TL, Hadigan CM, Grinspoon SK, Erlandson KM, Fourman LT.   +10 more
europepmc   +1 more source

Classification and Design of HIV-1 Integrase Inhibitors Based on Machine Learning. [PDF]

Comput Math Methods Med, 2021
Zhou J, Hao J, Peng L, Duan H, Luo Q, Yan H, Wan H, Hu Y, Liang L, Xie Z, Liu W, Zhao G, Hu J.   +12 more
europepmc   +1 more source

Associations between weight gain, integrase inhibitors antiretroviral agents, and gut microbiome in people living with HIV: a cross-sectional study. [PDF]

Sci Rep
De Greef J, Nguyen KN, Van Hul M, Puel A, Yombi JC, Vandercam B, Vincent A, Elens L, Belkhir L, Haufroid V, Cani PD.   +10 more
europepmc   +1 more source

Second-Generation Human Immunodeficiency Virus Integrase Inhibitors Induce Differentiation Dysregulation and Exert Toxic Effects in Human Embryonic Stem Cell and Mouse Models. [PDF]

J Infect Dis, 2022
Smith MR, Mohan H, Ajaykumar A, Hsieh AYY, Martineau L, Patel R, Gadawska I, Sherwood C, Serghides L, Piret JM, Côté HCF.   +10 more
europepmc   +1 more source

In vitro and patient studies with platelets to explore off-target cardiovascular effects of integrase inhibitors. [PDF]

HIV Med
Keniyopoullos R, Khawaja AA, Boffito M, Emerson M.   +3 more
europepmc   +1 more source

Rapid viral suppression using integrase inhibitors during acute HIV-1 infection. [PDF]

J Antimicrob Chemother
McKellar MS, Keys JR, Filiatreau LM, McGee KS, Kuruc JD, Ferrari G, Margolis DM, Eron JJ, Hicks CB, Gay CL.   +9 more
europepmc   +1 more source

Short and Long-term Body Weight Change Following the Switch to or the Addition of Integrase Inhibitors in Persons With HIV Differs by Sex. [PDF]

Clin Infect Dis
Lahiri CD, Mehta CC, Yang Q, Maramba T, Musonge-Effoe J, Yang CA, Dumond JB, Alcaide ML, Lake JE, Rubin LH, French AL, Cocohoba J, Kassaye SG, Sharma A, Palella FJ, Mellors J, Konkle-Parker D, Topper E, Augenbraun M, Ali MK, Sheth AN, Ziegler TR, Ofotokun I, Alvarez JA.   +23 more
europepmc   +1 more source

Changes in central adipose tissue after switching to integrase inhibitors. [PDF]

HIV Res Clin Pract, 2020
Debroy P, Feng H, Miao H, Milic J, Ligabue G, Draisci S, Besutti G, Carli F, Menozzi M, Mussini C, Guaraldi G, Lake JE.   +11 more
europepmc   +1 more source

Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018-2022. [PDF]

Front Cell Infect Microbiol
Lu X, Li Y, Liu M, Wang Y, An N, Sun D, Li Q.   +6 more
europepmc   +1 more source